Drug Chatter -- Tracking biopharma stock chatter

Profile for Myriad Genetics, Inc. (MYGN)

« Back to company index

MYGN Chatter Timeline

Stock Ticker for MYGN

Most Active Tweeters for MYGN

UserTweets
@SleekMoneycom 10
@biotech_sector 8
@dakotafinancial 8
@ChartMill 7
@IRAMarketReport 6

Recent Tweets for MYGN

midetimes @midetimes
Myriad Genetics’ $MYGN Overweight Rating Reiterated at Stephens https://t.co/FgcayWJqCA
September 25th 2017, 3:09am
dailypoliticaln @dailypoliticaln
Myriad Genetics’ $MYGN Overweight Rating Reiterated at Stephens https://t.co/IMSLt8YQSd
September 25th 2017, 3:09am
WKRBNews @WKRBNews
Myriad Genetics’ $MYGN Overweight Rating Reiterated at Stephens https://t.co/Q1lGa9lLqh
September 25th 2017, 3:09am
dailymailtimes @dailymailtimes
Myriad Genetics’ $MYGN Overweight Rating Reiterated at Stephens https://t.co/d24shb1bqq
September 25th 2017, 3:09am
SleekMoneycom @SleekMoneycom
Baillie Gifford & Co. Has $249.75 Million Stake in Myriad Genetics, Inc. $MYGN https://t.co/LVCYMjf8m1
September 25th 2017, 2:09am
BigWaveTrading @BigWaveTrading
Top Current Holding Update: $MYGN +98% in 7 1/4 months. Signal: 2/14. Entry: 2/15 @ 16.96. #trading #investing… https://t.co/1Y01XbCMDE
September 24th 2017, 3:09pm
chaffeybreeze @chaffeybreeze
Myriad Genetics, Inc. $MYGN Holdings Decreased by Prudential Financial Inc. https://t.co/joW5qPsmeX
September 24th 2017, 5:09am
IRAMarketReport @IRAMarketReport
Myriad Genetics, Inc. $MYGN Holdings Decreased by Prudential Financial Inc. https://t.co/Ivr5znRJAO
September 24th 2017, 5:09am
PolgarStocks @PolgarStocks
stockcharts: MYGN 33.79 Updated: 09-24-2017 $MYGN Last Trade: 9/22/2017 Last 33.79   -  Open 33.88 Previo https://t.co/TTYHMHGlzq
September 24th 2017, 5:09am
storminvestor @storminvestor
Myriad Genetics, Inc. $MYGN Given “Overweight” Rating at Stephens https://t.co/kN6jQFtHfC
September 23rd 2017, 12:09pm
SPNewsAnalysis @SPNewsAnalysis
Myriad Genetics, Inc. $MYGN Given “Overweight” Rating at Stephens https://t.co/mSBpxwLcRE
September 23rd 2017, 12:09pm
dakotafinancial @dakotafinancial
Myriad Genetics $MYGN Earning Somewhat Positive Press Coverage, Analysis Finds https://t.co/bsvKOIpmOU
September 23rd 2017, 9:09am
WatchlistN @WatchlistN
Schwab Charles Investment Management Inc. Trims Position in Myriad Genetics, Inc. $MYGN https://t.co/HdveuBNlrV
September 23rd 2017, 4:09am
dakotafinancial @dakotafinancial
Myriad Genetics, Inc. $MYGN Reaches New 52-Week High at $33.73 https://t.co/3OnZbCcDNh
September 23rd 2017, 3:09am
bankerstribune @bankerstribune
Stephens reiterated Myriad Genetics $MYGN at Overweight. This 10yr DCF shows nice Upside https://t.co/kfPllNEo5F
September 22nd 2017, 5:09pm
SPNewsAnalysis @SPNewsAnalysis
Myriad Genetics, Inc. $MYGN Expected to Post Quarterly Sales of $182.22 Million https://t.co/Y51coFhGpP
September 22nd 2017, 3:09pm
storminvestor @storminvestor
Myriad Genetics, Inc. $MYGN Expected to Post Quarterly Sales of $182.22 Million https://t.co/zuJEFmgmqJ
September 22nd 2017, 3:09pm
TheMarketsDaily @TheMarketsDaily
Myriad Genetics, Inc. $MYGN Position Boosted by Pinebridge Investments L.P. https://t.co/ij5GfmbCX3
September 22nd 2017, 10:09am
ZolmaxNews @ZolmaxNews
Myriad Genetics, Inc. $MYGN Shares Sold by GSA Capital Partners LLP https://t.co/cOQzD09lqq
September 22nd 2017, 10:09am
CFinancialNews @CFinancialNews
Myriad Genetics’ $MYGN “Overweight” Rating Reiterated at Stephens https://t.co/QkJ44WACtd
September 22nd 2017, 9:09am
intercooleronli @intercooleronli
Myriad Genetics’ $MYGN “Overweight” Rating Reiterated at Stephens https://t.co/UOFVHSEWcy
September 22nd 2017, 9:09am
RatingsNetwork @RatingsNetwork
Myriad Genetics's overweight rating reiterated at Stephens. $40.00 PT. https://t.co/gBb8l4Tzo0 $MYGN #MYGN
September 22nd 2017, 8:09am
ProVesting @ProVesting
$MYGN: Myriad Genetics (MYGN) PT Raised to $40 at Stephens: https://t.co/xjUeJQipaI
September 22nd 2017, 8:09am
pnani456 @pnani456
RT @AnalystWire: Myriad Genetics $MYGN PT Raised to $40 at Stephens https://t.co/MlYjpEIEb0
September 22nd 2017, 8:09am
AnalystWire @AnalystWire
Myriad Genetics $MYGN PT Raised to $40 at Stephens https://t.co/MlYjpEIEb0
September 22nd 2017, 8:09am
DavidTraderX @DavidTraderX
$mygn still showing strength even with market slowing
September 22nd 2017, 7:09am
SleekMoneycom @SleekMoneycom
Financial Survey: Myriad Genetics $MYGN versus Sequenom $SQNM https://t.co/qBJM3n8Lwk
September 21st 2017, 5:09pm
chaffeybreeze @chaffeybreeze
Myriad Genetics, Inc. $MYGN Reaches New 52-Week High at $33.73 https://t.co/YITsqL9MSu
September 21st 2017, 2:09pm
IRAMarketReport @IRAMarketReport
Myriad Genetics, Inc. $MYGN Reaches New 52-Week High at $33.73 https://t.co/BNthylDQet
September 21st 2017, 2:09pm
SPNewsAnalysis @SPNewsAnalysis
Head-To-Head Analysis: VAREX IMAGING $VREX versus Myriad Genetics $MYGN https://t.co/kUA67v9PIp
September 21st 2017, 9:09am
storminvestor @storminvestor
Head-To-Head Analysis: VAREX IMAGING $VREX versus Myriad Genetics $MYGN https://t.co/q7tMlqZGX0
September 21st 2017, 9:09am
DavidTraderX @DavidTraderX
$MYGN one of best performing biotechs of year #biotech #stockoftheday
September 21st 2017, 8:09am
SPNewsAnalysis @SPNewsAnalysis
State of Tennessee Treasury Department Decreases Position in Myriad Genetics, Inc. $MYGN https://t.co/xZAGJS35OV
September 21st 2017, 5:09am
storminvestor @storminvestor
State of Tennessee Treasury Department Decreases Position in Myriad Genetics, Inc. $MYGN https://t.co/BvrihdAttu
September 21st 2017, 5:09am
IRAMarketReport @IRAMarketReport
Myriad Genetics, Inc. $MYGN Holdings Reduced by Principal Financial Group Inc. https://t.co/3pF1AJxWDR
September 21st 2017, 5:09am
chaffeybreeze @chaffeybreeze
Myriad Genetics, Inc. $MYGN Holdings Reduced by Principal Financial Group Inc. https://t.co/SGKthz8MN9
September 21st 2017, 5:09am
storminvestor @storminvestor
Myriad Genetics’ $MYGN “Hold” Rating Reiterated at Cowen and Company https://t.co/62EexoRRYz
September 21st 2017, 2:09am
DavidTraderX @DavidTraderX
$MYGN great looking stock chart, up up and away
September 20th 2017, 9:09am
IRAMarketReport @IRAMarketReport
Myriad Genetics, Inc. $MYGN Short Interest Down 12.9% in August https://t.co/0uzqdaH9cH
September 20th 2017, 1:09am
chaffeybreeze @chaffeybreeze
Myriad Genetics, Inc. $MYGN Short Interest Down 12.9% in August https://t.co/KJdgbVwT7y
September 20th 2017, 1:09am
StockTexts @StockTexts
$MYGN Myriad Genetics, Inc. SEC Filing: Form 4 https://t.co/sNHhSRmye8
September 19th 2017, 5:09pm
InsiderAlertsIA @InsiderAlertsIA
$MYGN: New Insider Filing on President & C.E.O. MARK CHRISTOPHER CAPONE: https://t.co/rbX2mS67rr
September 19th 2017, 5:09pm
emq_news @emq_news
Head to Head Contrast: Myriad Genetics $MYGN versus Varex Imaging $VREX https://t.co/SOilr3N2M7
September 19th 2017, 2:09pm
TickerReport @TickerReport
Head to Head Contrast: Myriad Genetics $MYGN versus Varex Imaging $VREX https://t.co/dFHZL9t3Lc
September 19th 2017, 2:09pm
TickerReport @TickerReport
Head to Head Contrast: Myriad Genetics $MYGN versus Varex Imaging $VREX https://t.co/yrM5wMYmeh
September 19th 2017, 2:09pm
SleekMoneycom @SleekMoneycom
Analyzing Myriad Genetics $MYGN & Vascular Solutions $VASC https://t.co/JEWMuEVaaP
September 19th 2017, 8:09am
TranscriptDaily @TranscriptDaily
Myriad Genetics, Inc. $MYGN Stock Rating Reaffirmed by Cowen and Company https://t.co/R6Wq8m07mw
September 19th 2017, 3:09am
dakotafinancial @dakotafinancial
Brokerages Expect Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $182.22 Million https://t.co/oX1SRugyCm
September 19th 2017, 1:09am
CFinancialNews @CFinancialNews
Brokerages Expect Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $182.22 Million https://t.co/Lz3uDSQoiU
September 19th 2017, 1:09am
intercooleronli @intercooleronli
Brokerages Expect Myriad Genetics, Inc. $MYGN Will Post Quarterly Sales of $182.22 Million https://t.co/QSSczIrsEr
September 19th 2017, 1:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.